<p>DevoManc: Accessing England’s only fully integrated NHS testbed Colin Callow Welcome #DevoManc 3 DevoManc Health Innovation Manchester Click to edit Master title Health Innovation Manchester Introduction to an Academic Health Science System (AHSS) Discover Deliver Deploy Click to edit Master title Vision and Purpose Discover Deliver Deploy Click to edit Master title The rising costs of health and social care and slow introduction of innovative solutions are a major frustration to policy-makers and care providers Patien Outcome across Greater Manchester are currently below national averages against a range of disease and 20% Increase in over 65s population between 2011 and 2021 30% Increase in over 85s population between 2011 and 2021 £2b Funding deficit to the health economy by 2021 if no action is taken Fragmented and slow decision- making Structures which do not assist collaboration and co-ordination Lengthy and uncertain routes to adoption Excellent initiatives in one locality are not shared across the system Industry find multiplicity of organisations/ initiatives confusing and add to risk The obstacles preventing rapid implementation of innovations nationwide: mortality figures and over the next five years, faces significant public health challenges Click to edit Master title Discover Deliver Deploy Our vision is to be a recognised international leader in accelerating innovation that transforms citizens’ health and wellbeing ” “ Click to edit Master title We have established an ‘academic health science system’ that leverages the city region’s entire spectrum of exceptional clinical, academic and public assets, alongside industry innovators This syst m approach with shared focus and priorities, we are uniquely placed to shape & drive accelerated 2.8 million citizens The unique offering of Greater Manchester “ ” discovery, development & delivery of innovative digital, medical & health innovations Click to edit Master title Health Innovation Manchester brings together academic research and clinical excellence with industry innovators, creating shorter and more certain pathways to enable adoption at scale Health Innovation Manchester covers every stage of the translational pathway from discovery Health Innovation Manchester is building upon the strengths and synergies of both the AHSN & AHSC “ ” science through to commissioning and real world evaluation Click to edit Master title LOCAL REGIONAL NATIONAL Health Innovation Manchester will enhance Greater Manchester’s position, showcasing our city-region’s capabilities by aligning local, regional and national initiatives and strategies Our strategic priorities align with and support not only the Greater Manchester-wide Digital Strategy but also the Accelerating the discovery, development and deployment of innovation that improves our population’s health and wellbeing INTERNATIONAL Contributing to national and international health and life science policy Positioning Greater Manchester as an internationally renowned location for life science, med-tech and digital healthcare research and innovation NATIONAL national Accelerated Access Review and the Life Sciences Industrial Strategy, highlighting GM as an exemplar site Click to edit Master title The Innovation Pathway Discover Deliver Deploy Click to edit Master title Being at the heart of this unique and cohesive system ensures we have an in depth understanding and clear view of the needs of citizens, patients, providers and commissioners. Three major opportunities to highlight where system-wide innovation keeps people well, reduces pressure on health • Driven by exciting advances in basic research, particularly in genomics, digital technologies. • The development of health data analytics, using integrated big data sets. • Using exceptional insight into entire citizen-level health pathways, and the ability to evaluate treatments and care pathways. The future of healthcare and medicine will be • A streamlined and accelerated decision- making structures to aid industry in navigating disjointed systems. • We have signed an MOU with the Association of British Pharmaceutical Industries (ABPI) and are working closely with them to bring forward a pipeline of innovations for rapid adoption. A new approach to working with industry • Will enable us to tackle the perverse incentives in existing health and care funding which inhibit investment. • Evaluation of costs and benefits of innovations across the whole care pathway, outside of individual institutional boundaries. • Develop funding models which incentivise providers to invest in innovation. New business models and care providers, supports economic growth, and improves health outcomes for citizens and patients. Click to edit Master title The Innovation Pathway: providing structure, organisation and a systematic approach to translation and adoption through the health and social care system Adopti n and spread will be delivered through the Joint Commissioning and Provider Federation Boards, Active horizon scanning of innovations, targeted calls to industry and industry engagement to identify prioritised innovations Achieving the greatest and fastest possible improvement to the health and wellbeing of the 2.8 million people living in our region and beyond. Assessment against shared priorities for innovation with agreed criteria for evaluating and adopting proposals. nt of the feaibility and valu o the pr posal to the relevant pars of the health and care system. Clear and assured route f om ilot to adoptio acr ss all relvant providers, benefiting from our extensive experience in delivering service change. dopted ideas valuat d both quan itatively ad qualitatively to m asure benefits ag inst xpecta ions. c llective memoy of lessons e ned through the innovation pathway. Conv rting lessns learnt int evolving practice t en ure enduring improvements. stakeholder engagement, project management, economics and evaluation support Click to edit Master title Our exemplar projects will balance clinical need with innovation opportunity and support the work of population health and social care professionals, and the needs of primary and secondary care providers Exemplar projec s will be selected for their significant impact not only in improved patient outcomes but also for Medical Technologies & Diagnostics Ehealth & Informatics Service Delivery & Improvement Medicines Informatics & Analytics Precision Medicine Clinical Research Excellence Primary Care Secondary Care Mental Health Social Care Population Health their potential cost reduction to the health & social care system leading to positive impact in local economic activity Click to edit Master title Discover Deliver Deploy Accessing the NHS Accessing the NHS Keith Chantler • Single Hospital Service • Assured Access • www.intohealth.org • Business – how to engagement better with health & care Systems Topics Business Engagement With Health & Care Systems Must Do • Safe • Effective (clinical & economic) evidence) • (Increasingly) acceptable to patients • Affordable (Cost effective) Important • Clinical advantage • Implementable • Ideally transformational • Compelling business case We need innovations that help us to improve the care and delivery within and out of hospitals Helping people to stay well longer is critical Helping to manage at a distance is increasingly important – Manchester is piloting Internet of Things People matter – ask them what they want to better manage their particular circumstances Market pull -v- Technology push Panel session Jon Rouse Chief Officer Greater Manchester Health and Social Care Partnership Rowena Burns Executive Chair Health Innovation Manchester Keith Chantler Director of Innovation Central Manchester University Foundation Trust 23 Thank you #DevoManc </p>